Literature DB >> 19249579

Brain tumor stem cells: view from cell proliferation.

Yu Yao1, Xuqun Tang, Shiqi Li, Ying Mao, Liangfu Zhou.   

Abstract

A small population of TSCs, which form neurospheres and possess the capacity for self-renewal, has been recently identified in adult and pediatric brain tumors. They differentiate into phenotypically diverse populations, including neuronal, astrocytic, and oligodendroglial cells in vitro and recapitulate original tumors in vivo. The understanding of brain TSCs has been greatly advanced by the knowledge of cell proliferation, which contributes to initiate and sustain the malignant phenotype. In this article, the authors summarized the evidence of the presence of TSCs in human brain tumors and emphasized the significance of the proliferative status of TSCs. By analyzing the data, the authors found that CD133(+) cell-initiated glioblastomas have a higher proliferation index when compared to CD133(-) cells-induced glioblastomas. Furthermore, the relationship and difference of cell proliferation between TSCs and normal NSCs were reviewed. Finally, the preliminary evidence that TSCs in malignant brain tumors have more proliferative capacity than stem/progenitor cells in benign brain tumors was discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19249579     DOI: 10.1016/j.surneu.2008.09.016

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  2 in total

1.  Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human.

Authors:  Xuqun Tang; Yu Yao; Jingjing Zhu; Kunlin Jin; Yin Wang; Ying Mao; Liangfu Zhou
Journal:  Childs Nerv Syst       Date:  2012-07-20       Impact factor: 1.475

Review 2.  Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior.

Authors:  Giovanna Mantovani; Elena Giardino; Donatella Treppiedi; Rosa Catalano; Federica Mangili; Anna Spada; Maura Arosio; Erika Peverelli
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-25       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.